Charcot-Marie-Tooth Disease Market
- 2026 年市場規模
- USD 2,271.5 Mn
- 2033 年預估規模
- USD 9,896.5 Mn
- 年複合成長率 CAGR
- 23.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Charcot-Marie-Tooth Disease Market, By Disease Type (CMT 1, CMT 2, CMT 3, Others), By Drug Type (Nonsteroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors, Tricyclic antidepressants, Anticonvulsants, Analgesics, Pipeline Drug), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Charcot-marie-tooth (CMT) disease is caused by mutations in the genes that affect the structure and function of peripheral nerves that control movement and sensation. Defective genes can cause the nerve fibers (axons) or myelin sheaths (the fat layer that separates nerve fibers) to degenerate in the peripheral nerves. This weakens the transmission of nerve signals between the brain and limbs, causing muscle atrophy and decreased sensation. As charcot-marie-tooth disease progresses, symptoms will spread from the feet and legs to the hands and arms.
The severity of symptoms (that includes weakness in the legs, ankles, and feet, decreased muscle mass in the legs and feet, high foot arches, curled toes (hammer toes), and decreased walking and running ability, among others) varies from person to person, including between family members. The different types and subtypes of CMT are determined based on the mutant gene, genetic type, nerve conduction velocity, age of onset, disease severity, clinical symptoms, and peripheral nerve injury. The different types of CMT diseases include CMT1, CMT2, CMT3, CMT4, CMTX, and DICMT.
Market Dynamics
Increasing prevalence of charcot-marie tooth disease is one major factor driving the market growth. For instance, according to a data published by the Medscape in January 2021, the prevalence of CMT disease is one in 2,500 population, which is approximately 125,000 people in the U.S. The incidence of CMT 1 is 15 per 100,000 population; the incidence of CMT 1A is 10.5 per 100,000 population, or 70% of CMT 1. The incidence of CMT 2 is seven per 100,000 people. CMT X patients account for at least 10-20% of CMT syndrome patients.
Key features of the study
• This report provides in-depth analysis of the global charcot-marie-tooth disease market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global charcot-marie-tooth disease market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
• Key companies covered as a part of this study include Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp, Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global charcot-marie-tooth disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global charcot-marie-tooth disease market
Market Segmentation
• By Disease Type Insights (Revenue, USD Mn, 2021 - 2033)
o CMT 1
o CMT 2
o CMT 3
o Others
• By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
o Nonsteroidal anti-inflammatory drugs
o Cyclooxygenase-2 inhibitors
o Tricyclic antidepressants
o Anticonvulsants
o Analgesics
o Pipeline Drug
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players
o Addex Therapeutics Ltd.
o Affectis Pharmaceuticals AG
o Genzyme Corp
o Lead Discovery Center GmbH
o Pharnext SA
o Acceleron Pharma
o MedDay Pharmaceuticals
o Bristol-Myers-Squibb Company
o Inflectis Bio Science Health Company
o Helixmith Co., Ltd.
o Neurogene Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Disease Type
Market Snapshot, By Drug Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Market Opportunity Map
3. Global Charcot-Marie-Tooth Disease Market Insights
o Drivers
o Restraints
o Opportunity
o Impact Analysis
o Pipeline Analysis
o Market Trends
o Product Launches
o Key Developments
o Regulatory Scenario
o Collaborations & Acquisitions
o Epidemiology
o PEST Analysis
4. Global Charcot-Marie-Tooth Disease Market, By Disease Type, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o CMT 1
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o CMT 2
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o CMT 3
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
5. Global Charcot-Marie-Tooth Disease Market, By Drug Type, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Nonsteroidal anti-inflammatory drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Cyclooxygenase-2 inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Tricyclic antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Anticonvulsants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Analgesics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Pipeline Drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
6. Global Charcot-Marie-Tooth Disease Market, By Distribution Channel, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
7. Global Charcot-Marie-Tooth Disease Market, By Region, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Region at Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021–2033, (USD Million)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021–2033, (USD Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021–2033, (USD Million)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021–2033, (USD Million)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021–2033, (USD Million)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 – 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (USD Mn)
Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2021–2033, (USD Million)
o South Africa
o Central Africa
o North Africa
8. Competitive Snapshot
o Company Profiles
Addex Therapeutics Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Affectis Pharmaceuticals AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Genzyme Corp
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Lead Discovery Center GmbH
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Pharnext SA
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Acceleron Pharma
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
MedDay Pharmaceuticals
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Bristol-Myers-Squibb Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Inflectis Bio Science Health Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Helixmith Co., Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
Neurogene Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Market Strategies
9. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們